ImmuCell Corporation (ICCC)
NASDAQ: ICCC · IEX Real-Time Price · USD
4.160
-0.040 (-0.95%)
At close: Jul 19, 2024, 4:30 PM
4.170
+0.010 (0.24%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
ImmuCell Revenue
ImmuCell had revenue of $21.28M in the twelve months ending March 31, 2024, with 32.89% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $7.26M with 110.58% year-over-year growth. In the year 2023, ImmuCell had annual revenue of $17.47M.
Revenue (ttm)
$21.28M
Revenue Growth
+32.89%
P/S Ratio
1.53
Revenue / Employee
$269,402
Employees
79
Market Cap
32.50M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 17.47M | -1.10M | -5.90% |
Dec 31, 2022 | 18.57M | -675.01K | -3.51% |
Dec 31, 2021 | 19.24M | 3.90M | 25.43% |
Dec 31, 2020 | 15.34M | 1.62M | 11.80% |
Dec 31, 2019 | 13.72M | 2.74M | 24.91% |
Dec 31, 2018 | 10.99M | 555.21K | 5.32% |
Dec 31, 2017 | 10.43M | 887.13K | 9.30% |
Dec 31, 2016 | 9.54M | -684.73K | -6.69% |
Dec 31, 2015 | 10.23M | 2.63M | 34.64% |
Dec 31, 2014 | 7.60M | 1.59M | 26.46% |
Dec 31, 2013 | 6.01M | 617.24K | 11.45% |
Dec 31, 2012 | 5.39M | 278.79K | 5.45% |
Dec 31, 2011 | 5.11M | 724.95K | 16.53% |
Dec 31, 2010 | 4.39M | -119.56K | -2.65% |
Dec 31, 2009 | 4.51M | -122.55K | -2.65% |
Dec 31, 2008 | 4.63M | -1.44M | -23.74% |
Dec 31, 2007 | 6.07M | 1.27M | 26.41% |
Dec 31, 2006 | 4.80M | -181.87K | -3.65% |
Dec 31, 2005 | 4.98M | 1.29M | 34.82% |
Dec 31, 2004 | 3.70M | 338.94K | 10.10% |
Dec 31, 2003 | 3.36M | -2.83M | -45.72% |
Dec 31, 2002 | 6.18M | -492.06K | -7.37% |
Dec 31, 2001 | 6.68M | 1.04M | 18.47% |
Dec 31, 2000 | 5.64M | 726.74K | 14.80% |
Dec 31, 1999 | 4.91M | 427.38K | 9.54% |
Dec 31, 1998 | 4.48M | -74.81K | -1.64% |
Dec 31, 1997 | 4.56M | 116.49K | 2.62% |
Dec 31, 1996 | 4.44M | -497.34K | -10.07% |
Dec 31, 1995 | 4.94M | 498.78K | 11.24% |
Dec 31, 1994 | 4.44M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cutera | 196.64M |
IRIDEX | 49.92M |
Retractable Technologies | 40.20M |
ReWalk Robotics | 17.91M |
Longeveron | 978.00K |
Orgenesis | 529.00K |
ICCC News
- 12 days ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024 - GlobeNewsWire
- 6 weeks ago - ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain® - GlobeNewsWire
- 6 weeks ago - ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders - GlobeNewsWire
- 2 months ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024 - GlobeNewsWire
- 2 months ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024 - GlobeNewsWire
- 3 months ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024 - GlobeNewsWire
- 5 months ago - ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 - GlobeNewsWire
- 5 months ago - ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 - GlobeNewsWire